Literature DB >> 35723096

Characterization of Early Alzheimer's Disease-Like Pathological Alterations in Non-Human Primates with Aging: A Pilot Study.

Hannah M Jester1, Saahj P Gosrani1, Huiping Ding2, Xueyan Zhou1, Mei-Chuan Ko2, Tao Ma1,2,3.   

Abstract

BACKGROUND: Sporadic or late onset Alzheimer's disease (LOAD) is a multifactorial neurodegenerative disease with aging the most known risk factor. Non-human primates (NHPs) may serve as an excellent model to study LOAD because of their close similarity to humans in many aspects including neuroanatomy and neurodevelopment. Recent studies reveal AD-like pathology in old NHPs.
OBJECTIVE: In this pilot study, we took advantage of brain samples from 6 Cynomolgus macaques that were divided into two groups: middle aged (average age 14.81 years) and older (average age 19.33 years). We investigated whether AD-like brain pathologies are present in the NHPs.
METHODS: We used immunohistochemical method to examine brain Aβ pathology and neuron density. We applied biochemical assays to measure tau phosphorylation and multiple signaling pathways indicated in AD. We performed electron microscopy experiments to study alterations of postsynaptic density and mitochondrial morphology in the brain of NHPs.
RESULTS: We found multiple AD-like pathological alteration in the prefrontal cortex (but not in the hippocampus) of the older NHPs including tau hyperphosphorylation, increased activity of AMP-activated protein kinase (AMPK), decreased expression of protein phosphatase 2A (PP2A), impairments in mitochondrial morphology, and postsynaptic densities formation.
CONCLUSION: These findings may provide insights into the factors contributing to the development of LOAD, particularly during the early stage transitioning from middle to old age. Future endeavors are warranted to elucidate mechanisms underlying the regional (and perhaps cellular) vulnerability with aging and the functional correlation of such pathological changes in NHPs.

Entities:  

Keywords:  AMPK; Aging; Alzheimer’s disease; mitochondria; non-human primate; synapses

Mesh:

Substances:

Year:  2022        PMID: 35723096      PMCID: PMC9378582          DOI: 10.3233/JAD-215303

Source DB:  PubMed          Journal:  J Alzheimers Dis        ISSN: 1387-2877            Impact factor:   4.160


  99 in total

1.  Gray matter network associated with risk for Alzheimer's disease in young to middle-aged adults.

Authors:  Gene E Alexander; Kaitlin L Bergfield; Kewei Chen; Eric M Reiman; Krista D Hanson; Lan Lin; Daniel Bandy; Richard J Caselli; James R Moeller
Journal:  Neurobiol Aging       Date:  2012-03-08       Impact factor: 4.673

Review 2.  Alzheimer's disease is a synaptic failure.

Authors:  Dennis J Selkoe
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

Review 3.  Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.

Authors:  Tao Ma; Eric Klann
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

4.  Identification of Key Regulatory Genes and Pathways in Prefrontal Cortex of Alzheimer's Disease.

Authors:  Fuzhang Yang; Xin Diao; Fushuai Wang; Quanwei Wang; Jiamin Sun; Yan Zhou; Jiang Xie
Journal:  Interdiscip Sci       Date:  2020-01-31       Impact factor: 2.233

Review 5.  Molecular genetics of early-onset Alzheimer's disease revisited.

Authors:  Rita Cacace; Kristel Sleegers; Christine Van Broeckhoven
Journal:  Alzheimers Dement       Date:  2016-03-24       Impact factor: 21.566

6.  Aging African green monkeys manifest transcriptional, pathological, and cognitive hallmarks of human Alzheimer's disease.

Authors:  Paige E Cramer; Renee C Gentzel; Keith Q Tanis; Joshua Vardigan; Yi Wang; Brett Connolly; Philip Manfre; Kenneth Lodge; John J Renger; Celina Zerbinatti; Jason M Uslaner
Journal:  Neurobiol Aging       Date:  2017-12-20       Impact factor: 4.673

7.  Brain-specific repression of AMPKα1 alleviates pathophysiology in Alzheimer's model mice.

Authors:  Helena R Zimmermann; Wenzhong Yang; Nicole P Kasica; Xueyan Zhou; Xin Wang; Brenna C Beckelman; Jingyun Lee; Cristina M Furdui; C Dirk Keene; Tao Ma
Journal:  J Clin Invest       Date:  2020-07-01       Impact factor: 14.808

8.  Alzheimer's-like pathology in aging rhesus macaques: Unique opportunity to study the etiology and treatment of Alzheimer's disease.

Authors:  Amy F T Arnsten; Dibyadeep Datta; Shannon Leslie; Sheng-Tao Yang; Min Wang; Angus C Nairn
Journal:  Proc Natl Acad Sci U S A       Date:  2019-12-23       Impact factor: 11.205

9.  AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.

Authors:  Manon Domise; Sébastien Didier; Claudia Marinangeli; Haitian Zhao; Pallavi Chandakkar; Luc Buée; Benoit Viollet; Peter Davies; Philippe Marambaud; Valérie Vingtdeux
Journal:  Sci Rep       Date:  2016-05-27       Impact factor: 4.379

Review 10.  Hypothesis: Tau pathology is an initiating factor in sporadic Alzheimer's disease.

Authors:  Amy F T Arnsten; Dibyadeep Datta; Kelly Del Tredici; Heiko Braak
Journal:  Alzheimers Dement       Date:  2020-10-19       Impact factor: 16.655

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.